Stay updated on Evobrutinib Study in RMS Patients Clinical Trial

Sign up to get notified when there's something new on the Evobrutinib Study in RMS Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evobrutinib Study in RMS Patients Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record for the evobrutinib study in participants with relapsing multiple sclerosis is displayed, with study details, results measures, eligibility criteria, and supporting documents. It notes that the Phase 3 trial was terminated early and is no longer recruiting.
    Difference
    59%
    Check dated 2026-11-07T12:11:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:45:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T15:28:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T15:14:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer identifies the site revision as v3.7.1 instead of v3.7.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:19:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The NCT04032171 study page now renders a 403 Forbidden error, replacing the usual study record content. This change blocks access to the study details and related navigation, signaling restricted visibility of the page.
    Difference
    20%
    Check dated 2026-09-19T20:32:59.000Z thumbnail image

Stay in the know with updates to Evobrutinib Study in RMS Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evobrutinib Study in RMS Patients Clinical Trial page.